Pathological tumor response to neoadjuvant chemotherapy using anthracycline and taxanes in patients with triple-negative breast cancer

By                

Experimental and Therapeutic Medicine, Vol. 2, Iss. 2, 2011-01 ,pp. : 257-264

Spandidos Publications

Access to resources Recommend Favorite

Identification of a metabolic and canonical biomarker signature in Mexican HR+/HER2-, triple positive and triple-negative breast cancer patients

By  

International Journal of Oncology, Vol. 45, Iss. 6, 2014-01 ,pp. : 2549-2559

Spandidos Publications

Access to resources Recommend Favorite

Lower Level of MAPK Expression Is Associated with Anthracycline Resistance and Decreased Survival in Patients with Hormone Receptor Negative Breast Cancer

By Derin Duygu   Eralp Yesim   Ozluk Yasemin   Yavuz Ekrem   Guney Nese   Saip Pinar   Igci Abdullah   Ozmen Vahit   Kucucuk Seden   Aslay Isik   Aydiner Adnan   Topuz Erkan  

Cancer Investigation, Vol. 26, Iss. 7, 2008-08 ,pp. : 671-679

Informa Healthcare

Access to resources Recommend Favorite

Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations

By Bayraktar Soley  

Breast Cancer Research and Treatment, Vol. 130, Iss. 1, 2011-11 ,pp. : 145-153

Springer Publishing Company

Access to resources Recommend Favorite

Effect of neoadjuvant chemotherapy in patients with triple-negative breast cancer: A meta-analysis

By            

Oncology Letters, Vol. 9, Iss. 6, 2015-01 ,pp. : 2825-2832

Spandidos Publications

Access to resources Recommend Favorite